• WHO Pauses Trial of Hydroxychloroquine in COVID-19 Patients Due to Safety Concerns

    1 month ago - By Medscape

    The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to safety concerns, WHO Director General Tedros Adhanom Ghebreyesus said on Monday.
    Reuters Health Information
    Read more ...

     

  • WHO Stops Study Of Hydroxychloroquine Trial Over Safety Concerns

    1 month ago - By Scary Mommy

    The study was published in The Lancet late last week
    The World Health Organization is pausing clinical t rials that use hydroxychloroquine to treat COVID-19 patients after a medical journal published a paper last week stating patients taking hydroxychloroquine were dying at higher rates than those who were not.
    The Lancet reported that, not only did researchers not observe “ any benefit of hydroxychloroquine or chloroquine (when used alone or in combination with a macrolide) on in-hospital outcomes,” but that “ventricular arrhythmias were more common and mortality was higher” in the groups...
    Read more ...

     

  • Oxford Covid-19 trial of Trump-backed hydroxychloroquine is CONTINUING despite death fears

    Oxford Covid-19 trial of Trump-backed hydroxychloroquine is CONTINUING despite death fears

    1 month ago - By Daily Mail

    Oxford University researchers were given the green light by the UK drugs watchdog to continue giving the tablets to NHS patients with COVID-19 as part of the Recovery Trial.
    Read more ...